Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Enrollment begins in phase I study of AG-946

Sep. 9, 2020

Midwestern University describes isotopically stabilized tetronimide compounds

Sep. 7, 2020

S-62798 demonstrates efficacy in mouse model of thromboembolism

Sep. 7, 2020

University of California patents lentiviral vectors for hemoglobinopathies

Sep. 4, 2020

LNP-023 demonstrates efficacy, both as add-on and monotherapy, in patients with PNH

Sep. 3, 2020

Bristol-Myers Squibb reports phase I data for the antithrombotic milvexian

Sep. 2, 2020

First clinical data for TAFIa inhibitor S-62798 presented

Sep. 2, 2020

FDA clears IND for clinical development of OMS-906 for PNH

Sep. 1, 2020

Discovery of novel HIF-PHD2 inhibitors for the treatment of anemia

Sep. 1, 2020

Early clinical reports suggest utility of Aggrastat for COVID-19-related thrombotic complications

Aug. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...